A topoisomerase inhibitor that inhibits DNA topoisomerase (ATP-hydrolysing), EC 5.99.1.3 (also known as topoisomerase II and as DNA gyrase), which catalyses ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands.
A topoisomerase inhibitor that inhibits DNA topoisomerase IV, which catalyses ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands.
dextrofloxacin
(CHEBI:46577)
has role
antibacterial drug
(CHEBI:36047)
dextrofloxacin
(CHEBI:46577)
has role
DNA synthesis inhibitor
(CHEBI:59517)
dextrofloxacin
(CHEBI:46577)
has role
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
(CHEBI:50750)
dextrofloxacin
(CHEBI:46577)
has role
topoisomerase IV inhibitor
(CHEBI:53559)
dextrofloxacin
(CHEBI:46577)
is a
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(CHEBI:194135)
dextrofloxacin
(CHEBI:46577)
is a
fluoroquinolone antibiotic
(CHEBI:87211)
dextrofloxacin
(CHEBI:46577)
is a
quinolone antibiotic
(CHEBI:86324)
dextrofloxacin
(CHEBI:46577)
is enantiomer of
levofloxacin
(CHEBI:63598)